PTI is part of the Knowledge & Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Welcome. If you're a registered user, please log-in. If not, please sign-up.

VIEW AGENDA | DOWNLOAD AGENDA

Understanding and Preparing the Quality and Pharmaceutical Module of the Global CTD Dossier

24 - 26 October 2017

Radisson Blu Edwardian Grafton, London

Agenda

How to Prepare Module 3 of the Global CTD Dossier Training

View Agenda Register Study Online

This 3-day course will provide you with a clear understanding of the US and European regulatory requirements for Module 3 (CTD) of your application, and will show you how to compile this important part of your submission dossier. This course will teach you how to:

Compile and submit Module 3 (CTD) of your registration dossier
Ensure that Module 3 (CTD) of your dossier contains all data needed
Achieve the quickest turnaround for your submission
Deal effectively with regulators

Become more confident in your daily practices after three days of intensive lectures, group work, and discussion sessions, covering everything you need to know about compiling the chemistry and pharmacy section of your dossier.

This course is also available for studying online, check website for dates>>

Build Module 3 (CTD) of the dossier to meet regulatory requirements
Understand the legal framework and guidelines for the CMC/Quality part of the dossier
Meet the legal responsibilities of the manufacturing authorisation holder, and the designated qualified person
Write the application with a view to product maintenance and consistent supply
Define the impact of the Common Technical Document on the Quality section of the dossier
Write variation submissions for Europe and get approval first time
Structure your submission teams to ensure compliance
Link your dossier requirements to GMP
Minimise delays in your submission by providing accurate documentation
Use certificate of suitability as replacement of data

Andrew Willis has over 28 years' of experience in regulatory affairs and pharmaceutical development with specific knowledge in EU and US registrations, CMC regulatory requirements and multiple clinical aspects related to successful registration of drug products.

Previously Vice President of Regulatory Affairs and Consulting Services at Catalent Pharma Solutions, Andrew now works as an independent Regulatory Affairs and Pharmaceutical Development Consultant.

This course has been specifically designed to address the needs of:

Regulatory Affairs Managers/ Officers/ Assistants
Compliance Managers
Documentation Managers
Product Registration Personnel
Project Managers in Regulatory Affairs
Qualified Persons
Key contributors to the submission package

Very useful, interactive course with a practical approach!

Regulatory Affairs Specialist, Labesfal-Fresenius Kabi

How to Prepare Module 3 of the Global CTD Dossier Training

Very useful, interactive course with a practical approach!

You may also be interested in...

Filing Variations

Regulatory, Developmental and Manufacturing Challenges for ATMPs

A Practical Guide to Pharmacovigilance

A Beginners Guide to EU Regulatory Affairs - Online Academy

US-FDA Drug Submission Procedures

Regulatory Affairs Strategies

Understanding and Preparing the Quality and Pharmaceutical Module of the Global CTD Dossier - Online Academy

Pharmaceutical Regulatory Affairs in the EU and US

Introduction to Regulatory Affairs in the MENA Region

Regulatory Information Management and IDMP Training

Project Management for Regulatory Affairs Professionals

Regulatory Affairs for Clinical Trials

PTI Calendar of Events

Regulatory Affairs in Latin America

Advanced European Regulatory Affairs

eCTD Submissions

Fundamentals of European Regulatory Affairs

Gaining Marketing Authorisations in CIS for Pharmaceuticals and Biotech

Challenges in Drug/Device Combination Products

Mastering Regulatory and Development Strategies for Generics

EU & US Requirements for Pharmaceutical Labelling & Package Leaflets